Genetic effects of adiponectin on blood lipids and blood pressure.

Tongfeng Zhao,Jiangpei Zhao
DOI: https://doi.org/10.1111/j.1365-2265.2010.03902.x
2011-01-01
Clinical Endocrinology
Abstract:P>Objective Results from the published studies on the association of adiponectin gene (ADIPOQ) polymorphisms with blood lipids and blood pressure are conflicting. We investigated the association of three ADIPOQ polymorphisms, +45 T > G (rs2241766), +276 G > T (rs1501299) and -11377 C > G (rs266729), with these traits in this meta-analysis. Research design and methods We included 35 studies in this meta-analysis. Dominant models were used for this meta-analysis. Results We did not detect a significant association of the -11377 C > G polymorphism with blood lipids or blood pressure (P > 0 center dot 05). The association of the +45 T > G polymorphism with blood lipids and blood pressure was, similarly, not significant (P > 0 center dot 05). The meta-analysis suggested a significant overall association of the +276 G > T polymorphism with lower levels of total cholesterol: weighted mean difference (WMD) = -0 center dot 10, 95% confidence interval (CI, -0 center dot 17, -0 center dot 03), P = 0 center dot 005, P-heterogeneity = 0 center dot 04. This association was marginally significant in East Asians and East Asians with type 2 diabetes: WMD = -0 center dot 10, 95% CI (-0 center dot 20, 0 center dot 00), P = 0 center dot 05, P-heterogeneity = 0 center dot 002, and WMD = -0 center dot 09, 95% CI (-0 center dot 18, -0 center dot 00), P = 0 center dot 05, P-heterogeneity = 0 center dot 80, respectively. After exclusion of a study that was the source of heterogeneity, the association was significant in overall populations and marginally significant in East Asians: WMD= -0 center dot 06, 95% CI (-0 center dot 11, -0 center dot 01), P = 0 center dot 01, P-heterogeneity = 0 center dot 98, and WMD = -0 center dot 06, 95% CI (-0 center dot 12, 0 center dot 00), P = 0 center dot 07, P-heterogeneity = 0 center dot 83, respectively. However, none of these associations were significant after Bonferroni correction (significant threshold: P < 0 center dot 003). Conclusions Our meta-analysis does not suggest any association of the three ADIPOQ polymorphisms with blood lipids and blood pressure.
What problem does this paper attempt to address?